Hodgkin’s lymphoma in a patient on adalimumab treatment for psoriasis

Alballa, Nouf S; Alyousef, Alanoud M; AlAmari, AlBatool; Alhumidi, Ahmed; Zayed, Mohammed Ayesh; Zeitouni, Leena; Alsaif, Fahad

doi:10.21037/acr.2018.12.01

Cited by 4 publications

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2,3 The case we reported here developed an LPD after increasing the dosage of adalimumab. The development of various types of LPDs in patients treated with adalimumab has been previously described in other case reports, including Hodgkin lymphoma, 4,5 mycosis fungoides, 6 cutaneous anaplastic large cell lymphoma, 7 EBV-associated plasmablastic lymphoma, 8 hepatosplenic T-cell lymphoma, 9 and adult T-cell leukemia/lymphoma. 10 However, none of those studies reported on an EBV-positive T-cell lymphoma in the skin.…”

Section: Discussionmentioning

confidence: 55%

A Rare Case of Epstein-Barr Virus–Positive T-Cell Lymphoma in the Skin of an Immunocompromised Patient

Eijk

Koldijk

Kester

et al. 2021

The American Journal of Dermatopathology

View full text Add to dashboard Cite

:Immunodeficiency-associated lymphoproliferative disorders are associated with latent infection by Epstein–Barr virus (EBV). Most cases of EBV-positive immunodeficiency-associated lymphoproliferative disorders arise from B cells, although some are of T-cell or natural killer origin. Cutaneous involvement is unusual and sporadically reported in the literature. We describe a rare case of an EBV-positive T-cell lymphoma presenting in the skin of a 32-year-old woman using adalimumab for neurosarcoidosis.

show abstract